The common marmoset (Callithrix jacchus) as a model for neuroleptic-induced acute dystonia

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 4, 1997, Pages 947-953

  Fukuoka, Toshifumi ^a   Nakano, Minoru ^a   Kohda, Akira ^a   Okuno, Yasuyoshi ^a   Matsuo, Masatoshi ^a  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

Author keywords

Animal model; Common marmoset; Dystonia; Extrapyramidal side effects; Haloperidol

Indexed keywords

BROMPERIDOL; CHLORPROMAZINE; CLOZAPINE; DIAZEPAM; GRAMALIL; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE; RITANSERIN; SULPIRIDE; THIORIDAZINE; TIAPRIDE; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DYSKINESIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; IATROGENIC DISEASE; MARMOSET; MOTOR DYSFUNCTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREMOR;

ACUTE DISEASE; ANIMALS; ANTIPSYCHOTIC AGENTS; CALLITHRIX; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; DYSTONIA; FEMALE; HALOPERIDOL; MALE;

EID: 0031406536     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00314-6     Document Type: Article

References (27)

1. Bédard P., Delean J., Lafleur J., Larochelle L. Haloperidol-induced dyskinesias in the monkey. Can. J. Neurol. Sci. 4:1977;197-201.
2. Casey D. E., Gerlach J., Christensson E. Dopamine, acetylcholine and GABA effects in acute dystonia in primates. Psychopharmacology (Berlin). 70:1980;83-87.
3. Casey D. E., Keepers G. A. Neuroleptic side effects. Acute extrapyramidal syndromes and tardive dyskinesia Casey D.E., Christensen A. V. Psychopharmacology. Current trends:1988;74-93 Springer Verlag, Berlin.
4. Casey D. E. Antipsychotic drugs in schizophrenia. Newer compounds and differential outcomes Psychopharmacol. Bull. 27:1991;47-50.
5. 2 and serotonin mechanisms Schizophrenia. Proceedings of the Alfred Benzon Symposium:1995;38. vol. . Copenhagen: Munksgaard;: 287-297.
6. Casey D. E. Extrapyramidal syndromes and new antipsychotic drugs. Findings in patients and nonhuman primate models Br. J. Psychiatry. 168(Suppl. 29):1996;32-39.
7. Casey D. E. Behavioral effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeys. Psychopharmacology (Berlin). 124:1996;134-140.
8. Costall B., Naylor R. J. Neuroleptic and nonneuroleptic catalepsy. Arzneimittleforschung. 23:1973;674-683.
9. Deneau G., Crane G. E. Dyskinesia in rhesus monkeys tested with high doses of chlorpromazine. Crone G. E., Gardner J. R. A multidisciplinary workshop. Psychotropic drugs and dysfunctions of the basal ganglia:1969;12-14 Public Health Service Publications No. 1938, Washington, DC.
10. Domino E. F., Kovacic B. Monkey models of tardive dyskinesia. Mod. Probl. Pharmacopsychiatry. 21:1983;21-33.
11. Donlon P. T., Stenson R. L. Neuroleptic induced extrapyramidal symptoms. Dis. Nerv. Syst. 37:1976;629-635.
12. Dorris R. L., Dill R. E. Potentiation of haloperidol-induced catalepsy by ascorbic acid in rats and nonhuman primates. Pharmacol. Biochem. Behav. 24:1986;781-783.
13. Gunne L. M., Bárány S. Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology (Berlin). 50:1976;237-240.
14. Liebman J. M., Neale R. Neuroleptic-induced acute dyskinesias in squirrel monkeys. Correlation with propensity to cause extrapyramidal side effects Psychopharmacology (Berlin). 68:1980;25-29.
15. Malhotra A. K., Litman R. E., Pickar D. Adverse effects of antipsychotic drugs. Drug Safety. 9:1993;429-436.
16. Marder S. R., Meibach R. C. Risperidone in the treatment of schizophrenia. Am. J. Psychiatry. 151:1994;825-835.
17. Meldrum B. S., Anlezark G. M., Marsden C. D. Acute dystonia as an idiosyncratic response to neuroleptics in baboons. Brain. 100:1977;313-326.
18. 2 antagonist ritanserin. Psychopharmacol. Bull. 26:1990;373-376.
19. Neale R., Fallon S., Gerhardt S., Liebman J. M. Acute dyskinesias in monkeys elicited by halopemide, mezilamine and the 'antidyskinetic' drugs, oxiperomide and tiapride. Psychopharmacology (Berlin). 75:1981;254-257.
20. Neale R., Gerhardt S., Fallon S., Liebman J. M. Progressive changes in the acute dyskinetic syndrome as a function of repeated elicitation in squirrel monkeys. Psychopharmacology (Berlin). 77:1982;223-228.
21. Owens D. G. C. Extrapyramidal side effects and tolerability of risperidone. A review J. Clin. Psychiatry. Suppl. 55:1994;29-35.
22. Paulson G. W. Dyskinesias in monkeys. Huntington's chorea, Advances in Neurology, vol. 1. 1973;647-650 Raven Press, New York.
23. Porsolt R. D., Jalfre M. Neuroleptic-induced acute dyskinesias in rhesus monkeys. Psychopharmacology (Berlin). 75:1981;16-21.
24. Peuskens J. Risperidone in the treatment of patients with chronic schizophrenia. A multi-national, multi-centre, double-blind, parallel-group study vs haloperidol. Br. J. Psychiatry. 166:1995;712-726.
25. Rupniak N. M. J., Jenner P., Marsden C. D. Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berlin). 88:1986;403-419.
26. Weiss B., Santelli S., Lusink G. Movement disorders induced in monkeys by chronic haloperidol treatment. Psychopharmacology (Berlin). 53:1977;289-293.
27. Weiss B., Santelli S. Dyskinesias evoked in monkeys by weekly administration of haloperidol. Science. 200:1978;799-801.